Cellebrite DI Ltd. (CLBT) insider plans 653-share sale after prior dispositions

Rhea-AI Filing Summary

Cellebrite DI Ltd. affiliate David Gee filed to sell ordinary shares, par value NIS 0.00001, of Cellebrite DI Ltd. on Nasdaq. The planned sale covers 653 shares through Morgan Stanley Smith Barney LLC, connected to restricted share units that vested under an S-8 registered compensation plan.

Over the prior three months, David Gee reported sales of 228 shares, 2,243 shares, and 3,430 shares of the same class of ordinary shares, each with corresponding aggregate dollar values listed.

Key Figures

Shares to be sold: 653 shares Aggregate market value of planned sale: $10,212.92 Recent sale 1: 228 shares for $2,966.28 +3 more

6 metrics

Shares to be sold 653 shares Planned sale of ordinary shares through Morgan Stanley Smith Barney LLC

Aggregate market value of planned sale $10,212.92 Aggregate dollar value associated with the 653 shares to be sold

Recent sale 1 228 shares for $2,966.28 Ordinary shares sold on 05/12/2026

Recent sale 2 2,243 shares for $29,383.30 Ordinary shares sold on 05/21/2026

Recent sale 3 3,430 shares for $45,093.52 Ordinary shares sold on 05/21/2026

Par value NIS 0.00001 Par value per ordinary share of Cellebrite DI Ltd.

Key Terms

Restricted Share Units, S-8 Registered Plan, Ordinary shares, Form 144

4 terms

Restricted Share Units financial

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

S-8 Registered Plan regulatory

"Restricted Share Units Vested Under an Issuer S-8 Registered Plan"

Ordinary shares financial

"Ordinary shares, par value NIS 0.00001"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 07:44 AM Accepted by SEC EDGAR 08/07/2026 - 07:43 AM Learn about SEC filing dates

FAQ

What does the Form 144 filing by CLBT insider David Gee disclose?

The filing discloses that David Gee intends to sell 653 ordinary shares of Cellebrite DI Ltd. through Morgan Stanley Smith Barney. These shares relate to vested restricted share units under an S-8 registered compensation plan.

How many CLBT shares are proposed to be sold under this Form 144?

The filing shows a proposed sale of 653 ordinary shares of Cellebrite DI Ltd. The transaction is to be executed via Morgan Stanley Smith Barney LLC on the Nasdaq market.

What is the aggregate market value of the new CLBT shares to be sold?

The Form 144 lists an aggregate market value of $10,212.92 for the 653 ordinary shares to be sold. This figure reflects the total dollar amount associated with the proposed disposition.

What prior CLBT share sales by David Gee are reported in the last 3 months?

The filing reports sales of 228 shares for $2,966.28, 2,243 shares for $29,383.30, and 3,430 shares for $45,093.52 of Cellebrite DI Ltd. ordinary shares during the past three months.

How were the CLBT shares in this Form 144 obtained?

The shares are tied to restricted share units vested under an issuer S-8 registered compensation plan. This indicates the securities were acquired as part of Cellebrite DI Ltd.’s equity-based compensation arrangements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares, par value NIS 0.00001	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	653	10212.92	248581042	08/12/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary shares, par value NIS 0.00001	08/11/2026	Restricted Share Units Vested Under an Issuer S-8 Registered Plan	CELLEBRITE DI LTD.			653	08/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	05/12/2026	228	2966.28
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	05/21/2026	2243	29383.3
DAVID GEE 94 SHLOMO SHMELZER ROAD PETAH TIKVA L3 4970602	Ordinary shares, par value NIS 0.00001	05/21/2026	3430	45093.52

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)